Join the club for FREE to access the whole archive and other member benefits.

Genetic diversity, hoped to explain varied severity of COVID-19 symptoms

A look into DNA data from UK Biobank to answer many questions on the virus

14-Apr-2020

Key points from article :

UK Biobank, with its samples from 500,000 volunteers, now adding Covid-19 data.

To know why people without underlying health conditions can develop severe illness.

Answer questions such as: “What are the differences in their genetics?"

"Are there differences in the genes related to their immune response?"

"Are there differences in their underlying health?"

Researchers will be scouring the entire genome, searching for tiny variations in DNA.

Area of particular interest is ACE2 gene, which helps make a receptor allowing virus entry.

Past research show some diseases can make people with genetic variation, especially ill.

"Possibility that diversity in people’s response to COVID-19 rooted in virus' sequence diversity."

Another possibility: "it is rooted in patients' genetic diversity. Or a combination of both.”

Researchers from UK Biobank, Rockefeller University, University of Helsinki, and deCODE Genetics.

Mentioned in this article:

Click on resource name for more details.

Andrea Ganna

Senior Researcher, Institute for Molecular Medicine Finland

deCODE Genetics

Biopharmaceutical company, Iceland

Jean-Laurent Casanova

Professor, Rockefeller University; Investigator, Howard Hughes Medical Institute

Kari Stefansson

CEO of deCODE Genetics

Rory Collins

Principal Investigator and Chief Executive of UK Biobank

The Rockefeller University

Private graduate university in New York City.

UK BioBank

UK Biobank is a national and international health resource registered as a charity in Scotland

University of Helsinki

Multidisciplinary research university.

Topics mentioned on this page:
DNA Testing, Coronavirus